AMGEN INC — Director's Dealing 2012

Oct 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-10-24

Reporting Person: SHARER KEVIN W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-10-24	Common Stock	M	1391	$71.88	Acquired	102409	Direct
2012-10-24	Common Stock	M	193609	$71.88	Acquired	296018	Direct
2012-10-24	Common Stock	G	195000	—	Acquired	268494	Indirect
2012-10-24	Common Stock	G	195000	—	Disposed	101018	Direct
2012-10-24	Common Stock	S	235495	$88.0628	Disposed	32999	Indirect
2012-10-24	Common Stock	S	27505	$88.7202	Disposed	5494	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-24	Iso (Right to Buy)	$71.88	M	1391	Disposed	2013-04-03	Common Stock (1391)	Direct
2012-10-24	Nqso (Right to Buy)	$71.88	M	193609	Disposed	2013-04-03	Common Stock (193609)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4433.6295	Indirect

Footnotes

F1: These shares are being transferred to the reporting person's Living Trust.

F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,250 RSUs which fully vest on 4/28/2013; 22,750 RSUs which vest in two equal annual installments of 11,375 each commencing 4/26/2013; 60,000 RSUs which vest in two equal installments of 19,800 each on 4/25/2013 and 4/25/2014 and one installment of 20,400 on 4/25/2015; and 8,933 RSUs which vest in three installments of 2,947, 2,948 and 3,038 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.

F3: These shares include 85 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F4: The price reported is an average price. The prices ranged from $87.62 to $88.61 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F5: The price reported is an average price. The prices ranged from $88.62 to $89.11 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F6: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.